> R&D > Research PerformancesPatents
| NO | Patents |
|---|---|
| 1 | Method of Preparing Dendritic Cell, Dendritic Cell Prepared by the Same and Use Thereof |
| 2 | Method for Preparing Dendritic Cell With Increased Expression of Specific Genes And Composition For Preventing Or Treating Autoimmune Diseases Comprising Dendritic Cell Prepared By The Same |
| 3 | IFN-α Fusion Protein Comprising Interferon-α Linked to Cytoplasmic Transduction Peptide and Polyethylene glycol |
| 4 | A composition for maturation of Dendritic cell and a method of Preparing antigen-specific Dendritic Cell using the same |
| 5 | Method for preparing dendritic cells having potential to induce cancer specific immune response, pharmaceutical composition and kit for treating or preventing cancer or inhibiting cancer metastasis comprising the same |
| 6 | IFN-α fused protein having interferon-α and cytoplasmic transduction peptide |
| 7 | Method for preparing prostate acid phosphatase antigen for pulsing dendritic cells for prostate cancer immunotherapy |
| 8 | Autologous dendritic cell mediated by photodynamic therapy having the ability to suppress the growth of tumor |
| 9 | Pharmaceutical compositions for treating rheumatoid arthritis comprising semi-mature dendritic cell |
| 10 | Novel use of MLN51 gene and protein |
| 11 | Animal models carrying tumors expressing human liver cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics using the above |
| 12 | Animal models carrying tumors expressing human prostate cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics using the above |
| 13 | Method for Measuring Effectively the Activity of Cytotoxic T Lymphocyte in Human and Out-bred Animals |
| 14 | Novel Recombinant Sabin Type 1 Poliovirus Vector and Improved Recombinant Polio Vaccine Composition Using the Same |
| 15 | Novel Dendritic Cell-Specific Polynucleotides andMicroarray Comprising the Same |
| 16 | Novel recombinant poliovirus vectors and vaccine compositions capable of inducing cytotoxic T lymphocytes |
| 17 | Cytoplasmic Transduction Peptides and Uses thereof |
| 18 | Method for prepraring mature dendritic cell-vaccine for immunotherapy |
| 19 | Transgenic Escherichia coli transformed with pGM-CSF vector expressing recombinant mouse granulocyte-macrophage colony stimulating factor and method for mass production of the recombinant protein |
| 20 | The preparation method of recombinant human interleukin-4 |
| 21 | Pharmaceutical Compositions Comprising Dendritic Cells for Immunotherapy of Autoimmune Disease and Treatment Methods Using the Same |
| 22 | Method for Improving a Genetic Stability for the Insert in (+)-Single-Stranded RNA Virus Recombinant Vectors |
| 23 | SABIN TYPE 1 RECOMBINANT POLIOVIRUS VECTOR |
Theses
| NO | Research Papers |
|---|---|
| 1 | Increased synthesis of hyaluronic acid by enhanced penetration of CTP-EGF recombinant in human keratinocytes J Cosmet Dermatol 18(5):1539-1545 (2019) |
| 2 | A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma Br J Cancer 113(12)1666-76 (2015) |
| 3 | Dendritic cell-based therapeutic cancer vaccines: past, present and future. Clin Exp Vaccine Res 3(2):113-6 (2014) |
| 4 | Celastrol ameliorates HIV-1 Tat-induced inflammatory responses via NF-kappaB and AP-1 inhibition and heme oxygenase-1 inductionin astrocytes. Toxicol Appl Pharmacol 280(1):42-52 (2014) |
| 5 | Egr2 induced during DC development acts as an intrinsic negative regulator of DC immunogenicity Eur. J. Immunol 43(9):2484-96 (2013) |
| 6 | New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses EMBO reports 11(5):393-9 (2010) |
| 7 | Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice Eur J Immunol. 39(5):1334-43 (2009) |
| 8 | PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53 Proc Natl Acad Sci USA. 106(19):7852-7 (2009) |
| 9 | Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter Eur J Immunol. 39(3):858-68 (2009) |
| 10 | FLIP and MAPK play crucial roles in the MLN51-mediated hyperproliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis FEBS J. 275(14):3546-55 (2008) |
| 11 | The double-strand RNA-dependent protein kinase PKR plays a significant role in a sustained ER stress-induced apoptosis FEBS Letter 581(22):4325-32 (2007) |
| 12 | Phase I/II Study of Immunotherapy Using Autologous Tumor Lysate-pulsed Dendritic Cells Patients with Metastatic Renal Cell Carcinoma Clin. Cancer Immunol. 125(3):257-67 (2007) |
| 13 | DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors Cancer Immunol. Immunother. 56(11):1817-29 (2007) |
| 14 | MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis Arthritis Res Therapy (2006. 11.14, On-line published) 8(6):R170 |
| 15 | Cytoplasmic transduction peptide (CTP): New approach for the delivery of biomolecules into cytoplasm in vitro and in vivo Exp. Cell Res. 312(8):1277-88 (2006) |
| 16 | MAPK regulation and caspase activation are required in DMNQ S-52 induced apoptosis in Lewis lung carcinoma cells Cancer Lett. 233(1)57-67 (2006) |
| 17 | Newly Designed Six-Membered Azasugar Nucleotide-Containing Phosphorothioate Oligonucleotides as Potent Human Immunodeficiency Virus Type 1 Inhibitors Antimicrobial Agents and Chemoth 49(10):4110-20 (2005) |
| 18 | Present and Future of Dendritic cell-based Tumor Vaccine J Tissue Eng Regen Med 2:251-63 (2005) |
| 19 | Shiquandabutangjiaweibang inhibits tumor metastasis and angiogenesis via regulation of topoisomerase-1 J of Ethnopharmacol. 98(1-2):157-62 (2005) |
| 20 | Current trends and future in Dendritic cell-based tumor vaccine Trend in Health Industry and Technol. 20:17-29 (2004) |
| 21 | In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells Biochem. Biophys. Res. Comm. 321(1):102-8 (2004) |
| 22 | Human cytomegalovirus induces apoptosis in promonocyte THP-1 cells but not in promyeloid HL-60 cells Virus Res. 94(2):67-77 (2003) |
| 23 | Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis Blood 100(5):1742 -54 (2002) |
| 24 | Novel Design Architecture for Genetic Stability of Recombinant Poliovirus: the Manipulation of G/C Contents and Their Distribution Patterns Increases the Genetic Stability of Inserts in a Poliovirus-Based RPS-Vax Vector System J. Virol. 76(4):1649-62 (2002) |
| 25 | In vitro binding analysis of Hepatitis B virus-Pre-S derived putative helper T-cell epitopes to MHC class II molecules using stable HLA-DRB10405/-DRA0101 transfected cells IUBMB Life 50(6):379-84 (2001) |
| 26 | Prevention of Encephalomyocarditis Virus–Induced Diabetes by Live Recombinant Mycobacterium bovis Bacillus Calmette-Guérin in Susceptible Mice Diabetes 49(9):1459-67 (2000) |
| 27 | Truncated Form of Importin α Identified in Breast Cancer Cell Inhibits Nuclear Import of p53 J. Biol. Chem. 275(30):23139-45 (2000) |